Eden Research (LON:EDEN) Stock Falls 9.1% – Time to Sell?

Eden Research plc (LON:EDEN) shares dropped 9.1% during trading on Tuesday. The stock traded as low as GBX 3.34 and last traded at GBX 3.50. Approximately 6,988,454 shares were traded during trading, an increase of 1,038% from the average session volume of 614,134 shares. The stock had previously closed at GBX 3.85.

Eden Research Stock Up 1.6%

The business has a fifty day simple moving average of GBX 2.43 and a two-hundred day simple moving average of GBX 3.04. The company has a current ratio of 1.95, a quick ratio of 2.42 and a debt-to-equity ratio of 5.41. The company has a market cap of £26.11 million, a PE ratio of -7.33 and a beta of 1.55.

Eden Research (LON:EDEN) last announced its earnings results on Wednesday, August 26th. The company reported GBX (0.36) earnings per share (EPS) for the quarter. Eden Research had a negative return on equity of 16.16% and a negative net margin of 50.43%. As a group, equities research analysts predict that Eden Research plc will post -66.00 earnings per share for the current year.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.